[HTML][HTML] Ribosomal protein S6: a potential therapeutic target against cancer?
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
[HTML][HTML] Role of protein kinase CK2 in antitumor drug resistance
Drug resistance represents the major reason of pharmacological treatment failure. It is
supported by a broad spectrum of mechanisms, whose molecular bases have been …
supported by a broad spectrum of mechanisms, whose molecular bases have been …
[HTML][HTML] Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy–potential clinical relevance
Background Protein kinase CK2 inhibition has long been considered as an attractive anti-
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …
[HTML][HTML] Therapeutic targeting of CK2 in acute and chronic leukemias
F Buontempo, JA McCubrey, E Orsini, M Ruzzene… - Leukemia, 2018 - nature.com
CK2 is a ubiquitously expressed, constitutively active Ser/Thr protein kinase, which is
considered the most pleiotropic protein kinase in the human kinome. Such a pleiotropy …
considered the most pleiotropic protein kinase in the human kinome. Such a pleiotropy …
[HTML][HTML] LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21
X Zhou, P Yuan, Q Liu, Z Liu - Biomolecules & therapeutics, 2017 - ncbi.nlm.nih.gov
Imatinib resistance has become a major clinical problem for chronic myeloid leukemia. The
aim of the present study was to investigate the involvement of MEG3, a lncRNA, in imatinib …
aim of the present study was to investigate the involvement of MEG3, a lncRNA, in imatinib …
Small molecule modulators targeting protein kinase CK1 and CK2
Y Qiao, T Chen, H Yang, Y Chen, H Lin, W Qu… - European journal of …, 2019 - Elsevier
Casein kinase (CK) is a type of conserved serine/threonine protein kinase that
phosphorylates many important proteins in body. Researchers found that CK is involved in a …
phosphorylates many important proteins in body. Researchers found that CK is involved in a …
How can a traffic light properly work if it is always green? The paradox of CK2 signaling
CK2 is a constitutively active protein kinase that assuring a constant level of phosphorylation
to its numerous substrates supports many of the most important biological functions …
to its numerous substrates supports many of the most important biological functions …
[HTML][HTML] Specific inhibition of CK2α from an anchor outside the active site
P Brear, C De Fusco, KH Georgiou… - Chemical …, 2016 - pubs.rsc.org
The development of selective inhibitors of protein kinases is challenging because of the
significant conservation of the ATP binding site. Here, we describe a new mechanism by …
significant conservation of the ATP binding site. Here, we describe a new mechanism by …
Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells
T Ozkan, Y Hekmatshoar, AZ Karabay, A Koc… - Leukemia Research, 2021 - Elsevier
Abstract Introduction Chronic Myeloid Leukemia (CML) is a hematological disease which is
characterized by the presence of BCR-ABL fusion protein. Imatinib (IMA), a tyrosine kinase …
characterized by the presence of BCR-ABL fusion protein. Imatinib (IMA), a tyrosine kinase …
Long non-coding RNAs: the novel diagnostic biomarkers for leukemia
S Chen, H Liang, H Yang, K Zhou, L Xu, J Liu… - Environmental …, 2017 - Elsevier
Abstract Long non-coding RNAs (LncRNAs) are a category of non-coding RNAs (ncRNAs)
with a length of 200 nt–100 kb lacking a significant open reading frame. The study of …
with a length of 200 nt–100 kb lacking a significant open reading frame. The study of …